Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 07, 2018

SELL
$15.07 - $22.34 $3.3 Million - $4.89 Million
-219,042 Closed
0 $0
Q1 2018

Apr 27, 2018

BUY
$22.47 - $32.33 $4,494 - $6,466
200 Added 0.09%
219,042 $4.92 Million
Q4 2017

Feb 02, 2018

SELL
$26.84 - $39.14 $318,268 - $464,122
-11,858 Reduced 5.14%
218,842 $6.59 Million
Q3 2017

Nov 08, 2017

BUY
$29.49 - $38.37 $6.8 Million - $8.85 Million
230,700
230,700 $8.69 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Harvey Capital Management Inc Portfolio

Follow Harvey Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvey Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Harvey Capital Management Inc with notifications on news.